Mono-Methyl-P53 (Lys370) Monoclonal Antibody

Mono-Methyl-P53 (Lys370) Monoclonal Antibody

Introducing the MONO-METHYL-P53 (LYS370) Monoclonal Antibody, a cutting-edge product designed to revolutionize the field of molecular biology. This meticulously crafted antibody is specifically engineered to target and bind to the mono-methylated form of the p53 protein at the lysine 370 residue.

With utmost precision and accuracy, this monoclonal antibody offers unparalleled sensitivity and specificity, enabling researchers to delve deeper into the intricate mechanisms of p53 regulation. Its exceptional affinity for the mono-methylated p53 variant ensures reliable and reproducible results, facilitating a comprehensive understanding of this crucial protein's role in cellular processes.

Crafted with the utmost care and utilizing state-of-the-art technology, this monoclonal antibody guarantees exceptional performance across a wide range of applications. Whether employed in immunoprecipitation, Western blotting, immunofluorescence, or immunohistochemistry, researchers can rely on the MONO-METHYL-P53 (LYS370) Monoclonal Antibody to deliver consistent and robust results.

Furthermore, this antibody's exceptional specificity ensures minimal cross-reactivity with other proteins, thereby minimizing the risk of false-positive or inconclusive outcomes. Its high affinity and selectivity make it an indispensable tool for elucidating the intricate molecular pathways involving mono-methylated p53, paving the way for groundbreaking discoveries in cancer research and beyond.

The MONO-METHYL-P53 (LYS370) Monoclonal Antibody is meticulously manufactured under stringent quality control measures, guaranteeing batch-to-batch consistency and reliability. Each vial is accompanied by comprehensive documentation, including detailed protocols and technical specifications, to facilitate seamless integration into any laboratory setting.

In summary, the MONO-METHYL-P53 (LYS370) Monoclonal Antibody represents a breakthrough in molecular biology research, offering unparalleled sensitivity, specificity, and reliability. With its exceptional performance and meticulous manufacturing, this antibody is poised to empower researchers in unraveling the intricate complexities of p53 regulation, ultimately driving advancements in various fields, including cancer biology and therapeutics.